Pfizer Ltd
NSE:PFIZER

Watchlist Manager
Pfizer Ltd Logo
Pfizer Ltd
NSE:PFIZER
Watchlist
Price: 5 289.8999 INR 0.5%
Market Cap: 242B INR
Have any thoughts about
Pfizer Ltd?
Write Note

Pfizer Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pfizer Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Pfizer Ltd
NSE:PFIZER
Income from Continuing Operations
â‚ą6.2B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
16%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Income from Continuing Operations
â‚ą55.7B
CAGR 3-Years
47%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Income from Continuing Operations
â‚ą44.9B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Income from Continuing Operations
â‚ą111.4B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Income from Continuing Operations
â‚ą18B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Income from Continuing Operations
â‚ą19.4B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pfizer Ltd
Glance View

Market Cap
242B INR
Industry
Pharmaceuticals

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 2,285 full-time employees. The firm has a portfolio of approximately 150 products across over 15 therapeutic areas. The firm is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The firm offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The firm has its own manufacturing facility at Thane and Goa. The firm has various independent contract/third party manufacturers based across the country.

PFIZER Intrinsic Value
2 634.7856 INR
Overvaluation 50%
Intrinsic Value
Price

See Also

What is Pfizer Ltd's Income from Continuing Operations?
Income from Continuing Operations
6.2B INR

Based on the financial report for Sep 30, 2024, Pfizer Ltd's Income from Continuing Operations amounts to 6.2B INR.

What is Pfizer Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
16%

Over the last year, the Income from Continuing Operations growth was 18%. The average annual Income from Continuing Operations growth rates for Pfizer Ltd have been 2% over the past three years , 4% over the past five years , and 16% over the past ten years .

Back to Top